Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare In Brief

This article was originally published in The Gray Sheet

Executive Summary

MTWA covered: Cambridge Heart receives national coverage for its Heartwave II Microvolt T-Wave Alternans test March 21. The non-invasive test can identify patients who are unlikely to benefit from an implantable cardioverter defibrillator. ICD manufacturers, who argued against coverage during the public comment period, fear that the final decision represents an attempt by CMS to cut Medicare costs by reducing the ICD candidate population. The final coverage determination echoes CMS' Dec. 21 proposed decision, which requires use of Cambridge Heart's patented analytic spectral algorithm, but does not mandate MTWA testing for a patient to be eligible for an ICD (1"The Gray Sheet" Jan. 2, 2006, p. 6). Because General Electric's Marquette T-Wave Alternans device relies on a different algorithm than Cambridge Heart's, CMS says that all local carriers covering GE's device must halt coverage until the firm applies for an NCD...

Related Content

UsernamePublicRestriction

Register

MT023366

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel